JC
IMA

JBF Capital’s ImageneBio Inc IMA Stock Holding History

JBF Capital’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,054
Closed -$119K – 72
2024
Q4 		$119K Hold
6,054
– – 0.02% 69
2024
Q3 		$126K Hold
6,054
– – 0.02% 81
2024
Q2 		$120K Buy
+6,054
New +$107K 0.02% 78

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JBF Capital's IMA Position: Q1 2025 in Review

JBF Capital sold out of ImageneBio Inc (IMA) in Q1 2025, closing a stake of 6,054 shares — an estimated $119K sold.

JBF Capital first reported a position in IMA in Q2 2024 and held it in 3 quarters. The position peaked at $126K in Q3 2024. 45 funds tracked by Wall St. Rank hold IMA as of Q1 2025.

  • JBF Capital reported no remaining ImageneBio Inc position as of Q1 2025 after selling out during the quarter.
  • JBF Capital sold 6,054 ImageneBio Inc shares in Q1 2025, an estimated $119K.
  • JBF Capital first reported a position in ImageneBio Inc in Q2 2024 and held it in 3 quarters.
  • JBF Capital's ImageneBio Inc position peaked at $126K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2025.

Based on JBF Capital's 13F filing for Q1 2025, filed 8 May 2025.